Pennant International Group | PEN | AIM
Shares in Pennant International Group (LSE:PEN) have featured among London's small-cap fallers, prompting investors to take a fresh look at the defence-training and support-technology Business behind the ticker. The Cheltenham-based group is far from a household name, but it occupies a specialised niche — supplying Training systems, simulators and integrated logistics software to armed forces and regulated industries — that has become more topical as Western defence budgets expand and armies modernise ageing platforms. For a micro-cap dependent on a few large government contracts, sentiment can swing on the timing of awards, so a share-price slip often reflects the market recalibrating expectations rather than any change in the business.
What Pennant actually does
Pennant (LSE:PEN) operates across two broad areas. Its training systems division designs and builds simulators, courseware and technical training equipment for military and civil customers. Its faster-growing software arm centres on the Auxilium suite, which incorporates the former OmegaPS product, and is used to manage integrated logistics and through-life product support for complex platforms such as ships, aircraft and vehicles. Crucially, the software is sold on a recurring-licence basis, giving the group a growing base of predictable, high-margin Revenue alongside its more lumpy, project-driven systems work. That blend matters for the Investment case: the recurring software income smooths the peaks and troughs of contract-driven hardware sales and gradually raises the quality of group earnings.
The latest numbers
Results for the year to 31 December 2025, published in March 2026, revealed the strains of a transitional period. Revenue fell to around £10m from £13.8m the year before, as contract-award delays pushed work into later periods, while the statutory pre-tax loss narrowed to roughly £2.6m from £3m. More encouragingly, gross margins held near 50% and net Debt was cut sharply to about £0.2m from £2.3m following a restructuring that management says has created a stronger platform. Annual Recurring Revenue from the software business reached a record £2.4m, up from £1.9m, with the user base expanding around 8% and the group guiding for ARR to exceed £3m by the end of 2026. The sharply reduced net debt is significant for a company of this size, easing the pressure that can otherwise force dilutive fundraising.
A rebuilding order book
The forward-looking metrics are arguably more important than the headline loss. Pennant reported a three-year contracted order book of £23.3m, up from £15.9m, with roughly £9.7m scheduled for delivery in 2026 — around three-quarters of anticipated revenue for the year. Recent months have brought a steady flow of announcements: a new Auxilium agreement with a major global shipbuilder, a first Auxilium-GenS sale through a Partnership with Siemens, a multi-year integrated product support contract with Canada's Department of National Defence, and a teaming arrangement in Australia. Management has guided towards a return to break-even adjusted pre-tax profit and positive Operating Cash Flow in 2026, which would mark the pay-off from the restructuring.
Sector backdrop and risks
The macro backdrop is supportive. NATO members are lifting defence spending, and Demand for through-life support and training technology tends to follow procurement of new platforms. Pennant's software expansion into new geographies — including Germany, Denmark, Finland and the Czech Republic — and adjacent verticals such as space and robotics broadens its addressable market. Yet the risks remain material for a company of this size. Revenue is exposed to the timing of government contract awards, which can slip and distort year-on-year comparisons, and 2025 demonstrated exactly that vulnerability. Customer concentration, currency exposure from international work, and competition from larger support-services groups all weigh on the story. With cash resources modest, execution on converting the order book into billed revenue is the key swing factor, and any renewed delays could quickly pressure the business.
What to watch next
For now, the investment debate turns on whether the recovering order book and rising recurring revenue can translate into the sustained profitability management is targeting. Investors may watch the pace of Auxilium licence growth, the conversion of the training-systems pipeline into firm orders, and first-half 2026 trading for evidence that the turnaround is genuinely on track rather than merely deferred.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...